Sodium/Potassium-Transporting ATPase Subunit Beta-2: A Promising Drug Target and Biomarker

Target Name: ATP1B2

NCBI ID: G482

ATP1B2

Sodium/Potassium-Transporting ATPase Subunit Beta-2: A Promising Drug Target and Biomarker

Introduction

Sodium/potassium-transporting ATPase (ATPase) subunit beta-2 (尾2) is a protein that plays a crucial role in the regulation of intracellular sodium and potassium levels. It is a key component of the ATPase enzyme, which is responsible for generating ATP by catalyzing the transfer of a phosphate group from an ATP substrate to an ADP molecule. The activity of ATPase is highly regulated, and numerous studies have identified its potential as a drug target and biomarker. In this article, we will explore the biology of ATPase subunit beta-2 and its potential as a drug target.

Structure and Function

ATPase is a transmembrane protein that consists of two subunits: 尾1 and 尾2. The 尾1 subunit is responsible for the catalytic activity, while the 尾2 subunit is responsible for the regulatory activity. The 尾2 subunit plays a vital role in the regulation of intracellular sodium and potassium levels by allowing the reversible exchange of sodium and potassium ions across the membrane.

The 尾2 subunit is a 22-kDa protein that consists of 116 amino acids. It has a unique structure that includes a catalytic active site, a regulatory loop, and a cytoplasmic region. The catalytic active site is the site of the ATP-binding and hydrolysis, while the regulatory loop is responsible for the regulation of the activity of the enzyme. The cytoplasmic region is involved in the maintenance of the protein stability.

尾2 has been shown to play a crucial role in the regulation of intracellular sodium and potassium levels. It is a key component of the ATPase enzyme and is responsible for the reversible exchange of sodium and potassium ions across the membrane. Studies have shown that 尾2 has a high degree of accuracy in regulating the intracellular sodium and potassium levels, and alterations in 尾2 activity have been associated with various physiological processes, including muscle contractions, nerve impulse conduction, and heart rhythms.

Drug Target Potential

The 尾2 subunit of ATPase has been identified as a potential drug target due to its unique structure and its involvement in the regulation of intracellular sodium and potassium levels. Several studies have shown that modulation of 尾2 activity can have a significant impact on various physiological processes, including muscle contractions, nerve impulse conduction, and heart rhythms.

One of the potential drug targets for 尾2 is the inhibition of the activity of 尾2, which can lead to a decrease in the intracellular sodium and potassium levels. This can have a significant impact on various physiological processes, including muscle contractions, nerve impulse conduction, and heart rhythms.

Another potential drug target for 尾2 is the modulation of its stability. Studies have shown that the cytoplasmic region of 尾2 is involved in its stability, and alterations in this region can affect the activity of the enzyme. Therefore, drugs that can modulate the stability of 尾2 could be an effective drug target.

Biomarker Potential

The 尾2 subunit of ATPase has also been identified as a potential biomarker for various physiological processes, including heart failure, hypertension, and muscle weakness. Studies have shown that changes in the activity of 尾2 can be detected in the biochemical, cellular, and animal models of these diseases. Therefore, the 尾2 subunit has great potential as a biomarker for various physiological processes.

Conclusion

In conclusion, the 尾2 subunit of ATPase is a protein that plays a crucial role in the regulation of intracellular sodium and potassium levels. Its unique structure and function make it an attractive drug target, and its potential as a biomarker makes it an important area of research. Further studies are needed to fully understand the biology of 尾2 and its potential as a drug target and biomarker.

Protein Name: ATPase Na+/K+ Transporting Subunit Beta 2

Functions: This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The exact function of the beta-2 subunit is not known

The "ATP1B2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP1B2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets